Stryker Agrees to Pay $13.28 Million to Settle SEC Bribery Charges
The SEC charged the medical technology supplier with making hundreds of improper payments over several years.
Johnson & Johnson Helps the Dow Rise, but Will This Top Stock Keep Up?
Johnson & Johnson's medical device division's lackluster third quarter leaves investors wondering whether this key business will turn things around
Could Intuitive Surgical Make a Good Dividend Stock?
With growth opportunities dwindling, should Intuitive Surgical join Stryker and Medtronic in paying a dividend?
Is This Medical Device Maker Poised for Higher Growth?
Can Stryker keep outperforming the market by tapping into new opportunities in emerging markets and robotic surgeries?
Does the Robotic Surgery Industry Need Obamacare to Succeed?
Intuitive Surgical cited a lack of demand for its Da Vinci surgical systems for its disappointing results today. Would Obamacare's success actually help Intuitive Surgical and MAKO Surgical?
3 Words to Sum Up Where Intuitive Surgical Is and Where It's Heading
Here's the low-down on Intuitive Surgical's disappointing earnings release.
Is This Robotic Surgeon Broken Beyond Repair?
Will declining surgical robot sales, safety concerns, and bad press finally end Intuitive Surgical’s decade-long streak of astounding growth?